Sign in
4

Changes in Ownership

Matinas BioPharma Holdings, Inc. Filed Acc 0001493152-23-045172

Options or other derivatives

  • Chief Technology Officer acquired 1,000,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Derivatives
Liu Hui Chief Technology Officer 2023-12-15 Grant or award · Stock Option (right to Buy) +1,000,000 1,000,000 D
Loading xslF345X05/ownership.xml…